Rare diseases
Investigational molecules
Locations
Calle Del Doctor Castany S/N, 17190 Salt, Spain
Hospital Santa Caterina Ias in Salt, Spain specialises in clinical trials of conditions such as Multiple sclerosis, Multiple sclerosis relapse, Primary progressive multiple sclerosis, Relapsing multiple sclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in maternal health, focusing on improving the quality of life for pregnant women experiencing nausea and vomiting of pregnancy (NVP). Through innovative clinical trials, the center evaluates the efficacy of novel therapeutic combinations, such as the fixed-dose combination of doxylamine and pyridoxine, to alleviate symptoms and enhance well-being during pregnancy.
By advancing treatment options for NVP, the center contributes significantly to the field of obstetrics, ensuring better health outcomes for both mothers and their unborn children.
Specializing in neurology, the medical center conducts pivotal research on relapsing multiple sclerosis (RMS). The institution is dedicated to evaluating the efficacy and tolerability of advanced treatments, such as ofatumumab, compared to first-line disease-modifying therapies (DMTs). This research aims to provide newly diagnosed patients with more effective and personalized treatment options.
Through its commitment to cutting-edge research, the center plays a crucial role in enhancing therapeutic strategies for RMS, ultimately improving patient outcomes and quality of life.
Clinical trials currently enrolling participants at this site.
SpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
SpainStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
SpainA study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy
SpainStudy Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
SpainStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
SpainStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis
SpainStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
SpainStudy on Doxylamine and Pyridoxine for Pregnant Women with Nausea and Vomiting
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
